South West Women's Health Ltd 13551751 false 2024-09-01 2025-08-31 2025-08-31 The principal activity of the company is specialist medical practice activities Digita Accounts Production Advanced 6.30.9574.0 true true 13551751 2024-09-01 2025-08-31 13551751 2025-08-31 13551751 core:RetainedEarningsAccumulatedLosses 2025-08-31 13551751 core:ShareCapital 2025-08-31 13551751 core:CurrentFinancialInstruments 2025-08-31 13551751 core:CurrentFinancialInstruments core:WithinOneYear 2025-08-31 13551751 core:MotorVehicles 2025-08-31 13551751 core:OfficeEquipment 2025-08-31 13551751 core:PlantMachinery 2025-08-31 13551751 1 2025-08-31 13551751 bus:SmallEntities 2024-09-01 2025-08-31 13551751 bus:AuditExemptWithAccountantsReport 2024-09-01 2025-08-31 13551751 bus:FilletedAccounts 2024-09-01 2025-08-31 13551751 bus:SmallCompaniesRegimeForAccounts 2024-09-01 2025-08-31 13551751 bus:RegisteredOffice 2024-09-01 2025-08-31 13551751 bus:Director1 2024-09-01 2025-08-31 13551751 bus:PrivateLimitedCompanyLtd 2024-09-01 2025-08-31 13551751 core:MotorVehicles 2024-09-01 2025-08-31 13551751 core:OfficeEquipment 2024-09-01 2025-08-31 13551751 core:PlantMachinery 2024-09-01 2025-08-31 13551751 countries:EnglandWales 2024-09-01 2025-08-31 13551751 1 2024-09-01 2025-08-31 13551751 2024-08-31 13551751 core:MotorVehicles 2024-08-31 13551751 core:OfficeEquipment 2024-08-31 13551751 core:PlantMachinery 2024-08-31 13551751 1 2024-08-31 13551751 2023-09-01 2024-08-31 13551751 2024-08-31 13551751 core:RetainedEarningsAccumulatedLosses 2024-08-31 13551751 core:ShareCapital 2024-08-31 13551751 core:CurrentFinancialInstruments 2024-08-31 13551751 core:CurrentFinancialInstruments core:WithinOneYear 2024-08-31 13551751 core:MotorVehicles 2024-08-31 13551751 core:OfficeEquipment 2024-08-31 13551751 core:PlantMachinery 2024-08-31 13551751 1 2024-08-31 13551751 1 2023-09-01 2024-08-31 13551751 1 2023-08-31 iso4217:GBP xbrli:pure

Registration number: 13551751

South West Women's Health Ltd
Annual Report and Unaudited Filleted Financial Statements
for the Year Ended 31 August 2025

South West Women's Health Ltd

Contents

Company Information | 1
Balance Sheet | 2 to 3
Notes to the Unaudited Financial Statements | 4 to 7

South West Women's Health Ltd

Company Information

Director | N Crouch

Registered office | Spencer House Morston Court Aisecome Way Weston-Super-Mare North Somerset BS22 8NG

Accountants | Burton Sweet Limited Chartered Accounts & Business Advisers Spencer House Morston Court Aisecome Way Weston-Super-Mare North Somerset BS22 8NG

South West Women's Health Ltd

(Registration number: 13551751)
Balance Sheet
31 August 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Tangible assets | 4 | 39,000 | 51,114
Current assets |  |  |
Debtors | 5 | 28,905 | 39,395
Cash at bank and in hand |  | 74,452 | 7,554
|  | 103,357 | 46,949
Creditors: Amounts falling due within one year | 6 | (15,009) | (3,055)
Net current assets |  | 88,348 | 43,894
Net assets |  | 127,348 | 95,008
Capital and reserves |  |  |
Called up share capital |  | 100 | 100
Retained earnings |  | 127,248 | 94,908
Shareholders' funds |  | 127,348 | 95,008

South West Women's Health Ltd

(Registration number: 13551751)
Balance Sheet
31 August 2025

For the financial year ending 31 August 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the director on 12 May 2026

......................................... N Crouch Director

South West Women's Health Ltd

Notes to the Unaudited Financial Statements
Year Ended 31 August 2025

1 | General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Spencer House
Morston Court
Aisecome Way
Weston-Super-Mare
North Somerset
BS22 8NG
United Kingdom

These financial statements were authorised for issue by the director on 12 May 2026.

2 | Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

South West Women's Health Ltd

Notes to the Unaudited Financial Statements
Year Ended 31 August 2025

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales, returns, rebates and discounts.
The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 25% Reducing balance
Office equipment | 33% Straight line

3 | Staff numbers

The average number of persons employed by the company (including the director) during the year, was 1 (2024 - 1).

South West Women's Health Ltd

Notes to the Unaudited Financial Statements
Year Ended 31 August 2025

4 | Tangible assets

| Plant and machinery £ | Office equipment £ | Motor vehicles £ | Total £
Cost or valuation
At 1 September 2024 | 2,586 | 1,031 | 66,364 | 69,981
Additions | - | 1,084 | - | 1,084
Disposals | - | (658) | - | (658)
At 31 August 2025 | 2,586 | 1,457 | 66,364 | 70,407
Depreciation
At 1 September 2024 | 1,495 | 781 | 16,591 | 18,867
Charge for the year | 273 | 482 | 12,443 | 13,198
Eliminated on disposal | - | (658) | - | (658)
At 31 August 2025 | 1,768 | 605 | 29,034 | 31,407
Carrying amount
At 31 August 2025 | 818 | 852 | 37,330 | 39,000
At 31 August 2024 | 1,091 | 250 | 49,773 | 51,114

South West Women's Health Ltd

Notes to the Unaudited Financial Statements
Year Ended 31 August 2025

5 | Debtors

| 2025 £ | 2024 £
Other debtors | 28,905 | 39,395
| 28,905 | 39,395

6 | Creditors

Creditors: amounts falling due within one year

| 2025 £ | 2024 £
Due within one year |  |
Taxation and social security | 13,449 | 1,820
Accruals and deferred income | 1,560 | 1,235
| 15,009 | 3,055

7 | Related party transactions

Transactions with the director

2025 | At 1 September 2024 £ | Advances to director £ | Repayments by director £ | At 31 August 2025 £
Interest free and repayable on demand | 39,394 | 26,754 | (43,788) | 22,360

2024 | At 1 September 2023 £ | Advances to director £ | At 31 August 2024 £
Interest free and repayable on demand | - | 39,394 | 39,394